In a historic ruling, a judge in Michigan decided on August 8th that the Public Readiness and Emergency Preparedness (PREP) Act does not shield a drug manufacturer and a hospital in the case of a man who suffered two strokes and had to undergo a leg amputation due to receiving remdesivir, a COVID-19 medication that was contaminated with glass particles.
This marks the inaugural instance where a judge has determined that the PREP Act does not provide protection to a drug manufacturer or a hospital. The PREP Act typically grants immunity from legal actions and liability safeguards under both state and federal regulations for all claims related to losses arising from the use of the covered countermeasure. However, exceptions are made in cases of intentional misconduct. While this ruling is not a legally binding precedent, it establishes a precedent for potential future lawsuits against the company concerning injuries that could be sustained by individuals who were administered the...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
